Retraction notice to "Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state" [Neuroscience 262 (2014) 143-155];Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state

Neuroscience

Volumn 262, Issue , 2014, Pages 143-155

  Briones, T L ^a   Darwish, H ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cognitive aging; Glutathione; Superoxide dismutase; Water maze

Indexed keywords

CALCITRIOL; GLUTATHIONE; PHOSPHOPROTEIN PHOSPHATASE 2A; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TAU PROTEIN; CALCIUM; PHOSPHOPROTEIN PHOSPHATASE 2; VITAMIN; VITAMIN D;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CALCIUM BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING DISORDER; MALE; MEMORY DISORDER; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; COGNITION DISORDERS; DIET SUPPLEMENTATION; DRUG EFFECTS; FISCHER 344 RAT; HOMEOSTASIS; MAZE TEST; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RANDOMIZATION;

AGING; ANIMALS; CALCIUM; COGNITION DISORDERS; DIETARY SUPPLEMENTS; ENERGY METABOLISM; HIPPOCAMPUS; HOMEOSTASIS; MALE; MAZE LEARNING; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RANDOM ALLOCATION; RATS; RATS, INBRED F344; TAU PROTEINS; VITAMIN D; VITAMINS;

EID: 84893420835     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.009     Document Type: Erratum

References (65)

1. Annweiler C., Schott A.M., Rolland Y., Blain H., Herrmann F.R., Beauchet O. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 2010, 75:1810-1816.
2. Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O (2012) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol.
3. Annweiler C., Llewellyn D.J., Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2013, 33:659-674.
4. Atamna H., Frey W.H.n. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 2007, 7:297-310.
5. Augustinack J.C., Schneider A., Mandelkow E.-M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002, 103:26-35.
6. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
7. Boveris A., Navarro A. Brain mitochondrial dysfunction in aging. IUBMB 2008, 60:308-314.
8. Briones T.L., Darwish H. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J Neuroinflammation 2012, 9:244.
9. Briones T.L., Woods J., Wadowska M., Rogozinska M. Amelioration of cognitive impairment and changes in microtubule-associated protein 2 after transient global cerebral ischemia are influenced by complex environment experience. Behav Brain Res 2006, 168:261-271.
10. Briones T.L., Rogozinska M., Woods J. Environmental experience modulates ischemia-induced amyloidogenesis and enhances functional recovery. J Neurotrauma 2009, 24:613-625.
11. Brown J., Bianco J.I., McGrath J.J., Eyles D.W. 1,25-dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003, 343:139-143.
12. Buell J.S., Dawson-Hugues B. Vitamin D and neurocognitive dysfunction: preventing 'D'ecline?. Mol Aspects Med 2008, 29:415-422.
13. Calabrese V., Cornelius C., Mancuso C., Lentile R., Stella A.M., Butterfield D.A. Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol Biol 2010, 610:285-308.
14. Chung J.W., Jeon J.-H., Yoon S.-R., Choi I. Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases. J Dermatol 2006, 33:662-669.
15. Coudray C., O'Connor J.M., Maiani G., Cashman K.D., Simpson E.E., Secker D.L., Ferry M., Roussel A.M. Introduction to the ZENITH study and summary of baseline results. Eur J Clin Nutr 2005, 59(Suppl. 2):S5-S7.
16. Cui B., Zhu L., She X., Wu M.L., Ma Q., Wang T., Zhang N., Xu C., Chen X., An G., Liu H. Chronic noise exposure causes persistence of tau hyperphosphorylation and formation of NFT tau in the rat hippocampus and prefrontal cortex. Exp Neurol 2012, 238:122-129.
17. DeLuca G.C., Kimball S.M., Kolasinski J., Ramagopalan S.V., Ebers G.C. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013, 39:458-484.
18. Dringen R., Hamprecht B. Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev Neurosci 1998, 20:401-407.
19. Dringen R., Hirrlinger J. Glutathiones pathways in the brain. Biol Chem 2003, 384:505-516.
20. Dursun E., Gezen-Ak D., Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2010, 23:207-219.
21. Dusso AS (2013) Update on the biologic role of vitamin D on the endocrine system. Curr Vasc Pharmacol.
22. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D-3 and brain development. Neuroscience 2003, 118:641-653.
23. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29:21-30.
24. Eyles D., Almeras L., Benech P., Patatian A., Mackay-Sim A., McGrath J., Feron F. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 2007, 103:538-545.
25. Federico A., Cardaioli E., Da Pozzo P., Formichi P., Gallu G.N., Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012, 322:254-262.
26. Flynn J.M., Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Rad Biol Med 2013, 62:4-12.
27. Fryer L.G.D., Foufelle F., Barnes K., Baldwin S.A., Woods A., Carling D. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 2002, 363:167-174.
28. Fukui H., Moraes C.T. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?. Trends Neurosci 2008, 31:251-256.
29. Fuster-Matanzo A., Llorens-Martin M., Jurado-Arjona J., Avila J., Hernandez F. Tau protein and adult hippocampal neurogenesis. Front Neurosci 2012, 6:104.
30. Gibson G.E., Starkov A., Blass J.P., Ratan R.R., Beal M.F. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 2010, 1802:122-134.
31. Gong C.K., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2001, 275:5535-5544.
32. Gotz J., Xia D., Leinenga G., Chew Y.L., Nicholas H. What renders TAU toxic. Front Neurol 2013, 4:72.
33. Greer E.L., Dowlatshahi D., Banko M.R., Villen J., Hoang K., Blanchard D., Gygi S.P., Brunet A. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 2007, 17:1646-1656.
34. Harman D. Free radical theory of aging. Mutat Res 1992, 275:257-266.
35. Hashiguchi M., Hashiguchi Y. Kinase-kinase interaction and modulation of tau phosphorylation. Int Rev Cell Mol Biol 2013, 300:121-160.
36. Hu D., Klann E., Thieis E. Superoxide dismutase and hippocampal function: age and isozyme matter. Antioxid Redox Signal 2009, 9:201-210.
37. Iqbal K., Liu F., Gong C.-X., Alonso A.C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009, 118:53-69.
38. Johnson W.M., Wilson-Delfosse A.L., Mieyal J.J. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 2012, 4:1399-1440.
39. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
40. Kalueff A.V., Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007, 10:12-19.
41. Kapogiannis D., Mattson M.P. Disrupted energy metabolism and neural circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 2011, 10:187-198.
42. Kleman A.M., Yuan J.Y., Aja S., Ronnett G.V., Landree L.E. Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. J Neurosci Methods 2008, 167:292-301.
43. LaFrance R., Brustovetsky N., Sherburne C., Delong D., Dubinsky J.M. Age-related changes in regional brain mitochondria from Fischer 344 rats. Aging Cell 2005, 4:139-145.
44. Lebel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992, 5:227-231.
45. Liu C.L., Gotz J. How it all started: tau and protein phosphatase 2A. J Alzheimers Dis 2013, 37:483-494.
46. Liu R., Wang J.Z. Protein phosphatase 2A in Alzheimer's disease. Pathophysiology 2009, 16:273-277.
47. Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurocci 2005, 22:1942-1950.
48. Macleod J.E., Deleo J.A., Hickey W.F., Ahles T.A., Saykin A.J., Bucci D.J. Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res 2007, 181:168-172.
49. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247:3170-3175.
50. Morris R.G. Long-term potentiation and memory. Philos Trans R Soc Lond B Biol Sci 2003, 358:643-647.
51. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007, 292:C670-C686.
52. Navarro A., Lopez-Cepero J.M., Bandez M.J., Sanchez-Pino M.-J., Gomez C., Cadenas E., Boveris A. Hippocampal mitochondrial dysfunction in rat aging. Am J Physiol Regul Integr Comp Physiol 2008, 294:R501-R509.
53. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., Gillespie C., Hollis B.W., Looker A.C., Allen C., Doughertly C., Gunter E.W., Bowman B.A. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002, 76:187-192.
54. Nunomura A., Moreira P.I., Castellani R.J., Lee H.G., Zhu X., Smith M.A., Perry G. Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotox Res 2012, 22:231-248.
55. Planel E., Richter K.E., Nolan C.E., Finley J.E., Liu L., Wen P., Krishnamurthy P., Herman M., Wang L., Schachter J.B., Nelson R.B., Lau L.F., Duff K.E. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007, 27:3090-3097.
56. Ramcharitar J., Albrecht S., Afonso V.M., Kaushal V., Bennett D.A., Leblanc A.C. Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol 2013, 72:824-832.
57. Schmitt K., Grimm A., Kazmierczak A., Strosznajder J.B., Gotz J., Eckert A. Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau - a deleterious trio. Antioxid Redox Signal 2012, 16:1456-1466.
58. Shulman R.G., Rothman D.L., Behar K.L., Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 2004, 27:489-495.
59. Spach K.M., Hayes C.E. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005, 175:4119-4126.
60. Tuohimaa P., Keisala T., Minasyan A., Cachat J., Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009, 34S:S278-S286.
61. Winocur G., Hasher L. Age and time-of-day effects on learning and memory in a non-matching-to-sample test. Neurobiol Aging 2004, 25:1107-1115.
62. Winocur G., Vardy J., Binns M.A., Kerr L., Tannock I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006, 85:66-75.
63. Yap L.P., Garcia J.V., Han D., Cadenas E. The energy-redox axis in aging and age-related neurodegeneration. Adv Drug Deliv Rev 2009, 61:1283-1298.
64. Yin F., Boveris A., Cadenas E. Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal 2012, 10.1089/ars.2012.4774.
65. Yin F., Sancheti H., Cadenas E. Mitochondrial thiols in the regulation of cell death pathways. Antioxid Redox Signal 2012, 1010. 101089/ars.2012.4639.